Cannabis | Business Post

Marion McKeone: Potcom boom slow to hit but legal cannabis trade in US will be worth $100bn by 2030

Think Christmas Day meets Black Friday as concerts, rallies and discount deals are planed for 4/20 day in the US next week, while stoners complain their counter-culture day of pot-infused community activism has gone mainstream

Up for debate: The best from the Business Post’s columnists

Insightful analysis of the main developments in business and politics from our team of writers, including Elaine Byrne, Matt Cooper and Ian Guider

Elaine Byrne: We need to talk about cannabis, and about legalising it in Ireland

Gino Kenny’s bill to legalise cannabis for personal use presents a timely opportunity to discuss the realities around cannabis and its use today

Cowen-linked cannabis and cryptocurrency firm to raise $4m

Company with Brian Cowen on its advisory board plans to become the ‘Amazon of Cannabis’ and eliminate cash from legal cannabis purchases

Cowen back on board of Canadian cannabis and cryptocurrency firm

The former taoiseach had previously been on the advisory board of GetTangi Corporation, and has now returned following his 2019 stroke

Elaine Byrne: Anti-cannabis group has its say, but minister needs to listen to the other side

Frank Feighan, the minister in charge of the National Drugs Strategy, does not envisage legalising cannabis, but a legally regulated market would control what goes into cannabis, as well as generating revenue from taxes

Businessman secures stay on his prosecution for possessing cannabis products with trace amounts of THC

Judge says state must prove its prohibitions on cannabis products containing trace amounts of the psychoactive compound protect human health

State says legalising cannabis products containing THC is ‘premature’

The claim appeared in a legal challenge to the no-tolerance policy in Irish law for products containing the main psychoactive compound in cannabis

Jazz Pharmaceuticals wins approval for HSE reimbursement of cannabis-derived drug

The company acquired GW Pharma, the UK biopharma and producer of cannabis-derived Epidiolex, earlier this year

Elaine Byrne: Our conservative approach to medical cannabis is prolonging people’s suffering

The licensing of cannabis medication is overly bureaucratic, the products are expensive and reimbursement limited, so some individuals are risking prosecution by growing their own

Elaine Byrne: We need an honest debate on whether banning cannabis is more harmful than legalising it

The war on drugs has been a spectacular and costly failure, and it’s time to face reality instead of continuing our usual approach of ‘blissful ignorance’

Irish hemp farmers are operating in a legal grey area

Farmers and industry representatives say Irish law is holding back the development of a large-scale hemp industry, due to a no-tolerance policy over the cannabinoid compound THC, which forms part of the plant

Matt Cooper: Falling house of cards could take this government with it

The housing crisis hasn’t gone away, you know. It was only a matter of time until the fund-warped development model came back to bite those currently in power